The animal biotechnology market in Kuwait is expected to reach a projected revenue of US$ 24.8 million by 2030. A compound annual growth rate of 7.6% is expected of Kuwait animal biotechnology market from 2025 to 2030.
The Kuwait animal biotechnology market generated a revenue of USD 16.6 million in 2024 and is expected to reach USD 24.8 million by 2030.
The Kuwait market is expected to grow at a CAGR of 7.6% from 2025 to 2030.
In terms of segment, biologics was the largest revenue generating product in 2024.
Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
Animal biotechnology market data book summary
Market revenue in 2024
USD 16.6 million
Market revenue in 2030
USD 24.8 million
Growth rate
7.6% (CAGR from 2025 to 2030)
Largest segment
Biologics
Fastest growing segment
Biologics
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Diagnostics, Biologics, Drugs, Reproductive And Genetic, Nutrition
Key market players worldwide
Zoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN
Other key industry trends
In terms of revenue, Kuwait accounted for 0.1% of the global animal biotechnology market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, South Africa animal biotechnology market is projected to lead the regional market in terms of revenue in 2030.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 148.6 million by 2030.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Animal Biotechnology Market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 33.13% in 2024.
Horizon Databook has segmented the Kuwait animal biotechnology market based on diagnostics, biologics, drugs, reproductive and genetic, nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait Animal Biotechnology Market Product Outlook (Revenue, USD Million , 2018-2030)
Diagnostics
Biologics
Drugs
Reproductive And Genetic
Nutrition
Kuwait Animal Biotechnology Market Application Outlook (Revenue, USD Million , 2018-2030)
Diagnosis of Animal Diseases
Treatment of Animal Diseases
Preventive Care of Animals
Product Research & Development
Others
Kuwait Animal Biotechnology Market Animal Type Outlook (Revenue, USD Million , 2018-2030)
Companion
Livestock
Kuwait Animal Biotechnology Market End Use Outlook (Revenue, USD Million , 2018-2030)
Laboratories
Point-of-care testing/In-house testing
Veterinary Hospitals & Clinics
Others
Reasons to subscribe to animal biotechnology market report databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of animal biotechnology market report databook
Our clientele includes a mix of animal biotechnology market report companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait animal biotechnology market report, including forecasts for subscribers. This country databook contains high-level insights into Kuwait animal biotechnology market report from 2018 to 2030, including revenue numbers, major trends, and company profiles.